Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan-Reference-Cited by-同舟云学术

Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan

Published:2022-09 Issue:38 Volume:40 Page:5631-5640
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Matsuura Tomoka,Fukushima Wakaba,Nakagama Yu,Kido Yasutoshi,Kase Tetsuo,Kondo Kyoko,Kaku Natsuko,Matsumoto Kazuhiro,Suita Asae,Komiya Eriko,Mukai Emiko,Nitahara Yuko,Konishi Ayako,Kasamatsu Ayane,Nakagami-Yamaguchi Etsuko,Ohfuji Satoko,Kaneko Yukihiro,Kaneko Akira,Kakeya Hiroshi,Hirota Yoshio

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. mRNA-based therapeutics–developing a new class of drugs;Sahin;Nat Rev Drug Discov,2014

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

4. Association between 3 doses of mRNA COVID-19 Vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants;Accorsi;JAMA,2022

5. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial;Gilbert;Science,2022

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study;Vaccine;2024-10

2. Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China;Human Vaccines & Immunotherapeutics;2024-08-22

3. Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment;Frontiers in Immunology;2024-08-09

4. Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses;Scientific Reports;2024-03-27

5. Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination;Blood Neoplasia;2024-03